UK MHRA AI Scribe Guidance: Clarifying Regulatory Status of AI Medical Scribes

The UK's MHRA issued guidance on July 29, 2026, clarifying that certain Ambient Voice Technology (AVT), or 'AI scribes,' are not regulated as medical devices if their function is purely administrative. This episode details the specific functions, such as transcription and summarization for clinician review, that fall outside the regulation's scope. We explore how this clarification creates a faster, more streamlined path to the UK market for manufacturers and outline the critical steps that regulatory and quality teams should take in response.

Key Questions:
- What is the UK MHRA's new guidance on AI scribes and Ambient Voice Technology?
- When is an AI scribe officially considered a medical device in the United Kingdom?
- Which specific AI functions are now considered non-medical and outside the scope of regulation?
- How does this MHRA decision accelerate market access for AI technology in the UK?
- What is the crucial difference between a regulated clinical decision support tool and a non-regulated administrative AI?
- What are the immediate actions manufacturers should take to align with this new guidance?
- Does this UK-specific clarification impact regulatory requirements in the EU or the US?
- Why have some medical professional bodies raised concerns about this decision?
- How should companies define and document their product's intended purpose to ensure compliance?
- What are the risks of misrepresenting a product's function in marketing materials?

Sources:
- https://www.gov.uk/government/news/mhra-clarifies-regulatory-status-of-ambient-voice-technologies-used-in-the-nhs
- https://www.rcplondon.ac.uk/news/rcp-expresses-concern-over-mhra-decision-not-regulate-all-automated-voice-technologies-medical

How Pure Global can help:
Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access. We develop efficient regulatory strategies, manage technical dossier submissions, and act as your local representative in over 30 markets. Our unique approach combines in-country expertise with advanced AI tools to accelerate product registration and ensure ongoing compliance. Whether you are a startup or a multinational enterprise, we can help you navigate complex regulatory landscapes and get your products to patients faster. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.

Видео UK MHRA AI Scribe Guidance: Clarifying Regulatory Status of AI Medical Scribes канала Pure Global